JAMA Author Interviews podcast

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis

0:00
9:57
Reculer de 15 secondes
Avancer de 15 secondes

Joel M. Dulhunty, MD, PhD, Royal Brisbane and Women’s Hospital, and Jason A. Roberts, BPharm, PhD, University of Queensland Centre for Clinical Research, join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock.

Related Content:

D'autres épisodes de "JAMA Author Interviews"